NEW YORK, Dec. 2, 2011 /PRNewswire/ -- Levi & Korsinsky is investigating potential claims on behalf of long-term shareholders of Abbott Laboratories, Inc.

The maker of Similac powdered infant formulas said it is issuing a voluntary recall on millions of containers of the formula after beetles were found in the products and in a Michigan plant where they were produced.

WASHINGTON, June 22 /PRNewswire-FirstCall/ -- The Washington, D.C.-based law firm of Schmidt & Clark, LLP, is announcing the results of an inspection conducted by the U.S.

Advocates Claim Victory as Government Cuts & Freezes Price at $1,067 USD for Public Institutions and $1,591 USD for Hospitals, Clinics & Private Sector--55% Less than Abbott's Previous Colombian Price Since January, Colombian, Mexican & US AIDS Advocates Protested Steep Price of Drug in Developing Countries; Compulsory License in Colombia Would Further Cut Price to Less Than $600/Patient/Yearly MEXICO CITY, May 11 /PRNewswire-USNewswire/ -- Colombian and international AIDS advocates and activists claimed victory today after the government of Colombia announced that it will cut the price of Abbott Laboratories' lifesaving AIDS drug, Kaletra to $1,067 USD for the public sector hospitals and clinics and $1,591 USD for the private sector.

By Tom Daykin, Milwaukee Journal Sentinel Mar. 1--Global pharmaceutical maker Abbott Laboratories Inc.'s long-range plans to expand into southeastern Wisconsin are expected to be the subject of a Thursday announcement Gov. Jim Doyle.